PCSK9 and cancer: However, extrahepatic functions of PCSK9 are increasingly studied in the last three years, involving cardiomyocyte [31], endotheliocyte [32], macrophage, and cancer cell metabolism [33], shedding light on possible therapeutic uses of PCSK9 inhibitors to new off-label clinical applications in cardio-oncology.